Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Zoia AntyshevaFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.ORCID 0000-0003-2982-2123
Anton EsibovFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Ekaterina AvsievichFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.ORCID 0000-0002-4563-650X
Ekaterina PetriaikinaFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.
Vladimir YudinFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.ORCID 0000-0002-9199-6258
Anton KeskinovFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.
Sergey YudinFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.ORCID 0000-0002-7942-8004
Dmitry SvetlichnyyFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.ORCID 0000-0002-3776-9871
Julia KrupinovaFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Aleksey IvashechkinFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.ORCID 0000-0002-0148-1112
Yulia KatsaranFederal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal medical and biological agency (Centre for Strategic Planning of the Federal medical and biological agency), 119121 Moscow, Russia.ORCID 0009-0005-4238-0755
Mary WoroncowFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Veronika SkvortsovaThe Federal Medical Biological Agency (FMBA of Russia), 123182 Moscow, Russia.
Viktor BogdanovFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.ORCID 0000-0001-6377-9056
Pavel VolchkovFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 125315 Moscow, Russia.
Funding
Ministry of Science and Higher Education of the Russian Federation FGFG-2025-0016Ministry of Science and Higher Education of the Russian Federation FSMG-2024-0029
6 · The paper itself
Abstract
This case report describes a novel intronic mutation,
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Case of Salt-Wasting Congenital Adrenal Hyperplasia Caused by a Rare Intronic Variant in the · full record | OpenQuestion